Trials / Completed
CompletedNCT04996693
On Dose Efficiency of Modern CT-scanners in Chest Scans
On Dose Efficiency of Modern CT-scanners in Chest Scans- a Prospective, Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 958 (actual)
- Sponsor
- University Hospital Augsburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CT scans of the chest / thorax are of great importance both in the initial diagnosis and in the follow-up of pulmonary or thoracic diseases. As an example, CT angiography of the pulmonary arteries (CTPA) is worldwide considered to be gold standard test in patients with a suspicion for pulmonary embolism. The aim of this study is to measure and compare dose efficiency of modern CT scanners for unenhanced and contrast-enhanced scan protocols of the chest/thorax. Patients who are referred for a CT of the chest/thorax will be randomly assigned to one of the three CT scanners currently in use at our institution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Imaging on Scanner with Spectral Imaging Capabilities | Patients will undergo imaging on a modern CT scanner with spectral imaging capabilities. A dose neutral spectral acquisition mode will routinely be used. Contrast material protocol and scan ranges are similar in all three arms. |
| DIAGNOSTIC_TEST | CT Scan using an Energy-Integrating Detector CT (128 slice MDCT) | Patients will undergo imaging on a modern 128-slice CT scanner (Siemens Healthineers) with energy-integrating detector and without spectral acquisition mode. Contrast material protocol and scan ranges are similar in all three arms. |
| DIAGNOSTIC_TEST | CT Scan using an Energy-Integrating Detector CT (20-slice MDCT) | Patients will undergo imaging on a modern 20-slice CT scanner (Siemens Healthineers) with energy-integrating detector and without spectral acquisition mode. Contrast material protocol and scan ranges are similar in all three arms. |
Timeline
- Start date
- 2021-10-07
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2021-08-09
- Last updated
- 2023-11-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04996693. Inclusion in this directory is not an endorsement.